Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ENROLLING BY INVITATION
NCT07443202
PHASE2
Study of Lotilaner Ophthalmic Gel in Patients With Ocular Rosacea (KORE)
Sponsor: Tarsus Pharmaceuticals, Inc.
View on ClinicalTrials.gov
Summary
To evaluate lotilaner treatment in patients with ocular rosacea.
Official title: A Randomized, Vehicle-Controlled, Multicenter, Double-Masked, Parallel, Phase 2 Study to Evaluate the Safety, Tolerability and Exploratory Efficacy of Lotilaner Ophthalmic Gel in Participants With Ocular Rosacea (KORE)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
155
Start Date
2025-12-05
Completion Date
2027-12-31
Last Updated
2026-03-02
Healthy Volunteers
No
Conditions
Interventions
DRUG
lotilaner
lotilaner
DRUG
Vehicle
Vehicle of lotilaner
Locations (2)
Site
Houston, Texas, United States
Site
Lynchburg, Virginia, United States